Collegium to Participate in 23rd Annual Needham Virtual Healthcare Conference

STOUGHTON, Mass., April 03, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced that management will participate in a fireside chat at the 23^rd Annual Needham Healthcare Conference being held virtually from April 8-11, 2024.

Details of the event are as follows:
Fireside Chat Date and Time: Wednesday, April 10, 2024, at 3:45 p.m. ET

The fireside chat will be webcast live and can be accessed from the Investors section of the Company's website: https://ir.collegiumpharma.com. A replay of the webcast will be archived on the Company's website for 90 days following the presentation.

About Collegium Pharmaceutical, Inc.
Collegium is a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the Company’s website at www.collegiumpharma.com.

Investor Contact:
Christopher James, M.D.
Vice President, Investor Relations
[email protected]

Media Contact:
Marissa Samuels
Vice President, Corporate Communications
[email protected]

You May Also Be Interested In

• Elevara Medicines Appoints Biotech Veteran as CEO
• Agarwoodie Launches Jewelry Line Using 100% Pure, 300-Year-Old Wild Indonesian Agarwood
• Nucleome Therapeutics strengthens global IP portfolio with US patent for core MCC Technology